Related Experiment Video
Updated: Jun 17, 2026

Preparing and Rearing Axenic Insects with Tissue Cultured Seedlings for Host-Gut Microbiota Interaction Studies of the Leaf Beetle
Published on: October 8, 2021
Gut microbes: from bugs to drugs
1Department of Medicine and Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Cork, Ireland. F. Shanahan@ucc.ie
Abstract:
A poorly appreciated truism is that the information contained within the mammalian genome is insufficient for full development of several organ systems, notably the gut, immune system, and other sensory organs. The required information is derived from the environment, including the microbial environment. This suggests that the microbiota is a source of regulatory signals, some of which may be suitable for exploitation for therapeutic purposes. Indeed, it could have been deduced from comparative studies of germ-free and conventionally colonized animals almost half a century ago that the gut microbiota influences the development and maturation of the digestive and immune systems. In some instances, the signals involved have recently been defined molecularly. This opens the possibility of a "bugs to drugs" program of discovery, in which the gut ecosystem is explored as a repository from which bioactives or novel drugs might be mined and translated to human health care. Specific examples of mining microbe-microbe interactions, host-microbe interactions, and host-microbe-dietary interactions have immediate clinical implications. The future of drug discovery in gastroenterology is likely to reside in the lumen!
Insights
The mammalian genome requires environmental input, including microbial signals, for proper organ development. Exploring the gut microbiota offers a novel "bugs to drugs" approach for discovering new therapeutics.
Area of Science:
- Microbiology
- Developmental Biology
- Pharmacology
Background:
- Mammalian development relies on both genomic information and environmental cues.
- The gut microbiota plays a crucial role in the development and maturation of the digestive and immune systems.
- Specific molecular signals mediating host-microbe interactions are increasingly being identified.
Purpose of the Study:
- To highlight the necessity of environmental information, particularly from the microbiota, for mammalian development.
- To propose the gut ecosystem as a source for novel drug discovery.
- To explore the therapeutic potential of microbial signals and interactions.
Main Methods:
- Comparative studies of germ-free and conventionally colonized animals.
- Molecular definition of microbial signaling molecules.
- Analysis of microbe-microbe, host-microbe, and host-microbe-dietary interactions.
Main Results:
- The gut microbiota significantly influences the development of key organ systems.
- Molecular insights into host-microbe signaling are emerging.
- Interactions within the gut ecosystem offer potential for therapeutic exploitation.
Conclusions:
- The gut microbiota is an essential source of regulatory information for mammalian development.
- A
- bugs to drugs
- paradigm is feasible for discovering novel therapeutics.
- Future drug discovery in gastroenterology will likely leverage insights from the gut lumen and its microbial inhabitants.
Related Concept Videos
Microbiota Modulation by Antibiotics
Functions of the Gut Microbiota
Microorganisms in Medicine and Therapeutics
Introduction to the Human Microbiota
Gut-Brain Axis
Microorganisms in Agriculture and Food industry

